The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the most epidemic liver disorder worldwide as a result of rapid lifestyle transformation over the past few decades and is expected to elevate in the next few years as well as it is ranging from plain hepatic steatosis via non-alcoholic...

Full description

Bibliographic Details
Main Authors: Fayed Attia Koutb Megahed, Xiaoling Zhou, Pingnan Sun, Marwa Mohamed Elmaghrabi
Format: Article
Language:English
Published: SpringerOpen 2021-03-01
Series:Egyptian Liver Journal
Subjects:
Online Access:https://doi.org/10.1186/s43066-021-00084-w
_version_ 1818336830069669888
author Fayed Attia Koutb Megahed
Xiaoling Zhou
Pingnan Sun
Marwa Mohamed Elmaghrabi
author_facet Fayed Attia Koutb Megahed
Xiaoling Zhou
Pingnan Sun
Marwa Mohamed Elmaghrabi
author_sort Fayed Attia Koutb Megahed
collection DOAJ
description Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the most epidemic liver disorder worldwide as a result of rapid lifestyle transformation over the past few decades and is expected to elevate in the next few years as well as it is ranging from plain hepatic steatosis via non-alcoholic steatohepatitis (NASH) to liver cirrhosis and hepatocellular carcinoma (HCC). Main text NAFLD can also stimulate the diseases progression as diabetes and cardiovascular. Therefore, understanding the NAFLD pathogenesis is of vital clinical interest additionally is a crucial for disease treatment and prevention. After analyzing NAFLD and liver diseases prevalence, it has been a belief regarding the interaction between NAFLD and chronic hepatitis B (CHB). Conclusion The liver is an essential innate immune organ with large numbers of innate immune cells that contribute in NAFLD pathogenesis, additionally play the influential role that control NAFLD progression in the hepatitis B patients. Here, we summarized the recent advances in understanding and managing the NAFLD patients with chronic hepatitis B infection and interplay with innate immunity.
first_indexed 2024-12-13T14:45:33Z
format Article
id doaj.art-35e89a8f84824935a464f9b7662cef4b
institution Directory Open Access Journal
issn 2090-6226
language English
last_indexed 2024-12-13T14:45:33Z
publishDate 2021-03-01
publisher SpringerOpen
record_format Article
series Egyptian Liver Journal
spelling doaj.art-35e89a8f84824935a464f9b7662cef4b2022-12-21T23:41:29ZengSpringerOpenEgyptian Liver Journal2090-62262021-03-0111111110.1186/s43066-021-00084-wThe interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patientsFayed Attia Koutb Megahed0Xiaoling Zhou1Pingnan Sun2Marwa Mohamed Elmaghrabi3Stem Cell Research Center, Research Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical CollegeStem Cell Research Center, Research Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical CollegeStem Cell Research Center, Research Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology, Shantou University Medical CollegeCenter of Excellence for Research in Regenerative Medicine and Applications, Faculty of Medicine, Alexandria UniversityAbstract Background Non-alcoholic fatty liver disease (NAFLD) is the most epidemic liver disorder worldwide as a result of rapid lifestyle transformation over the past few decades and is expected to elevate in the next few years as well as it is ranging from plain hepatic steatosis via non-alcoholic steatohepatitis (NASH) to liver cirrhosis and hepatocellular carcinoma (HCC). Main text NAFLD can also stimulate the diseases progression as diabetes and cardiovascular. Therefore, understanding the NAFLD pathogenesis is of vital clinical interest additionally is a crucial for disease treatment and prevention. After analyzing NAFLD and liver diseases prevalence, it has been a belief regarding the interaction between NAFLD and chronic hepatitis B (CHB). Conclusion The liver is an essential innate immune organ with large numbers of innate immune cells that contribute in NAFLD pathogenesis, additionally play the influential role that control NAFLD progression in the hepatitis B patients. Here, we summarized the recent advances in understanding and managing the NAFLD patients with chronic hepatitis B infection and interplay with innate immunity.https://doi.org/10.1186/s43066-021-00084-wHBVFatty liverNAFLDNASHInnate immunity
spellingShingle Fayed Attia Koutb Megahed
Xiaoling Zhou
Pingnan Sun
Marwa Mohamed Elmaghrabi
The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
Egyptian Liver Journal
HBV
Fatty liver
NAFLD
NASH
Innate immunity
title The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
title_full The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
title_fullStr The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
title_full_unstemmed The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
title_short The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
title_sort interplay between non alcoholic fatty liver disease and innate immunity in hepatitis b virus patients
topic HBV
Fatty liver
NAFLD
NASH
Innate immunity
url https://doi.org/10.1186/s43066-021-00084-w
work_keys_str_mv AT fayedattiakoutbmegahed theinterplaybetweennonalcoholicfattyliverdiseaseandinnateimmunityinhepatitisbviruspatients
AT xiaolingzhou theinterplaybetweennonalcoholicfattyliverdiseaseandinnateimmunityinhepatitisbviruspatients
AT pingnansun theinterplaybetweennonalcoholicfattyliverdiseaseandinnateimmunityinhepatitisbviruspatients
AT marwamohamedelmaghrabi theinterplaybetweennonalcoholicfattyliverdiseaseandinnateimmunityinhepatitisbviruspatients
AT fayedattiakoutbmegahed interplaybetweennonalcoholicfattyliverdiseaseandinnateimmunityinhepatitisbviruspatients
AT xiaolingzhou interplaybetweennonalcoholicfattyliverdiseaseandinnateimmunityinhepatitisbviruspatients
AT pingnansun interplaybetweennonalcoholicfattyliverdiseaseandinnateimmunityinhepatitisbviruspatients
AT marwamohamedelmaghrabi interplaybetweennonalcoholicfattyliverdiseaseandinnateimmunityinhepatitisbviruspatients